The Simple Version
When an investor funds a pre-revenue startup, they are buying a bet on a future that doesn’t exist yet. The check isn’t payment for what you’ve built. It’s payment for what they believe you could build, in a market they think will be large enough to matter.
That sounds obvious until you watch a founder spend six months polishing a product for a pitch when the investor was never going to fund the product in the first place.
What’s Actually on the Table
Imagine two founders walk into the same pitch meeting. Both have a prototype that does the same thing. Both are targeting the same market. One gets the term sheet. One gets a polite email two days later.
The difference is almost never the product. At the pre-revenue stage, the product is almost always too early to be the deciding variable. What the investor bought was the person, the market read, and the theory of why this company could become hard to kill.
This matters because it changes how you should think about your own pitch. You are not presenting evidence that your product works. You are presenting evidence that you will figure it out, that the market is real and large, and that something structural about your position makes you the right team to capture it.
Those are three different arguments, and most founders collapse them into one slide deck that addresses none of them clearly.
The Founding Team Is the Asset
Venture investors will tell you, in public, that they back great teams. This is one of those clichés that is actually true.
At the pre-revenue stage, the product is a hypothesis. The market size is a spreadsheet. The only thing you can actually evaluate with some rigor is whether this founding team has the pattern of skills and judgment that tends to produce good companies. Prior domain expertise. Evidence of learning fast. The ability to sell (to investors, to early employees, to first customers). Some indication that they’ve done hard things before and didn’t quit.
Paul Graham has written about this directly: Y Combinator’s early bet was often on whether a founder was the kind of person who would push through the inevitable disasters. Not on whether the current idea was the right one, because the idea often changed anyway.
This is cold comfort if you’re a first-time founder without obvious credentials. But the frame is still useful, because it tells you what to demonstrate during a pitch. Don’t just describe your product. Show how you think. Show that you’ve already been wrong about something and updated. Show that you know more about this specific problem than anyone in the room.
Market Size Is Not a Formula, It’s a Worldview
The other thing investors are buying is a picture of the world where your company matters.
The standard advice is to show a large total addressable market. This advice is correct but usually executed badly. Founders find a big number from a research report, put it on a slide, and think they’ve addressed the question. They haven’t.
What an experienced investor wants to know is: do you understand why this market is large, and do you have a credible theory for how you get from here to capturing a meaningful slice of it? Those are harder questions than “is the TAM big?”
Bezos didn’t pitch Amazon as “the books market.” He pitched it as everything. That read on the market, right or wrong, was the asset. The investor who funded the early rounds was buying into a particular worldview about what e-commerce could become, not a valuation of the books market in 1994.
You don’t have to be right about the world. You have to be coherent and specific enough that the investor can decide whether they share your view. The ones who do will fund you. The ones who don’t, won’t, and that’s fine.
The Structural Bet: Why You and Why Now
There’s a third thing being purchased, and it’s the least discussed: defensibility.
At pre-revenue, you can’t demonstrate a moat. But you can make a case for why one might form. Distribution advantages. Proprietary data that accumulates over time. Network effects that kick in at scale. Regulatory relationships. Deep technical knowledge that’s genuinely hard to replicate quickly.
Investors know that premature scaling kills more startups than bad ideas, and they also know that plenty of good ideas get executed by the wrong team in the wrong moment and die anyway. What they’re looking for in a pre-revenue company is some early indication that if you do get this right, the outcome is durable. That a well-funded competitor can’t just copy you in six months.
This is also why the “why now” question matters more than founders expect. The answer isn’t “because technology has advanced.” The answer is a specific, argued case for why the conditions that make this company possible and defensible exist today and didn’t exist three years ago. Timing is a structural argument, not a sales pitch.
What This Means Practically
If you take all of this seriously, a few things follow.
First, investor-product fit matters as much as product-market fit at the pre-revenue stage. An investor who doesn’t share your worldview about where the market is going will be a bad partner even if they write the check. They’ll push you in the wrong direction at every board meeting.
Second, if you’re not getting traction in pitches, the problem is probably not your deck. It’s one of the three things: the team story isn’t landing, the market read isn’t credible, or the structural argument is missing. Redesigning slides won’t fix those.
Third, the money itself is the least interesting thing about a good early investor. What you’re buying back from them is their network, their judgment on specific decisions, and the signal their name sends to your next round. The wrong customer almost killed Slack, Spotify, and YouTube by pulling them in the wrong direction. The wrong early investor can do the same thing.
The check is not the product of the relationship. It’s the beginning of it. Make sure you understand what both sides are actually purchasing.
